Related references
Note: Only part of the references are listed.Regulation and Function of NF-kappa B Transcription Factors in the Immune System
Sivakumar Vallabhapurapu et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
The microenvironment in mature B-cell malignancies: a target for new treatment strategies
Jan A. Burger et al.
BLOOD (2009)
Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance
Antonina V. Kurtova et al.
BLOOD (2009)
Rel A Is an Independent Biomarker of Clinical Outcome in Chronic Lymphocytic Leukemia
Saman Hewamana et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Difference in the Relative Distribution of CD4+ T-cell Subsets in B-CLL With Mutated and Unmutated Immunoglobulin (Ig) VH Genes Implication for the Course of Disease
Inge Tinhofer et al.
JOURNAL OF IMMUNOTHERAPY (2009)
The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target
Saman Hewamana et al.
BLOOD (2008)
Significantly shorter telomeres in T-cells of patients with ZAP-70+/CD38+ chronic lymphocytic leukaemia
Alexander Roeth et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
The Novel Nuclear Factor-κB Inhibitor LC-1 Is Equipotent in Poor Prognostic Subsets of Chronic Lymphocytic Leukemia and Shows Strong Synergy with Fludarabine
Saman Hewamana et al.
CLINICAL CANCER RESEARCH (2008)
Novel insights in chronic lymphocytic leukemia: Are we getting closer to understanding the pathogenesis of the disease?
Federico Caligaris-Cappio et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation
P. Ghia et al.
JOURNAL OF INTERNAL MEDICINE (2008)
Hedgehog-Induced Survival of B-Cell Chronic Lymphocytic Leukemia Cells in a Stromal Cell Microenvironment: A Potential New Therapeutic Target
Ganapati V. Hegde et al.
MOLECULAR CANCER RESEARCH (2008)
CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential
Silvia Deaglio et al.
BLOOD (2007)
Statins revert doxorubicin resistance via nitric oxide in malignant mesothelioma
Chiara Riganti et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia
Stephanie Haiat et al.
IMMUNOLOGY (2006)
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
JA Burger et al.
BLOOD (2006)
Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells
M Burger et al.
BLOOD (2005)
Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1α
M Nishio et al.
BLOOD (2005)
Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells
G Görgün et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells
A Petlickovski et al.
BLOOD (2005)
Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract
JV Fahey et al.
HUMAN REPRODUCTION (2005)
Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia
G Packham et al.
IMMUNOLOGY (2005)
Interleukin-8 induces nuclear transcription factor-κB through a TRAF6-dependent pathway
SK Manna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mechanisms of disease: Chronic lymphocytic leukemia
N Chiorazzi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Autocrine expression of platelet-derived growth factor B in B cell chronic lymphocytic leukemia
CL Ho et al.
ACTA HAEMATOLOGICA (2005)
Differential effects on CLL cell survival exerted by different microenvironmental elements
P Ghia et al.
CHRONIC LYMPHOCYTIC LEUKEMIA (2005)
The two NF-κB activation pathways and their role in innate and adaptive immunity
G Bonizzi et al.
TRENDS IN IMMUNOLOGY (2004)
The Akt pathway: Molecular targets for anti-cancer drug development
CS Mitsiades et al.
CURRENT CANCER DRUG TARGETS (2004)
Cytokine modulation of nuclear factor-κB activity in B-chronic lymphocytic leukemia
A Zaninoni et al.
EXPERIMENTAL HEMATOLOGY (2003)
Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia
MR Rezvany et al.
BLOOD (2003)
Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia
S Lanham et al.
BLOOD (2003)
RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF
ZB Yilmaz et al.
EMBO JOURNAL (2003)
CD40 regulates the processing of NF-κB2 p100 to p52
HJ Coope et al.
EMBO JOURNAL (2002)
BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells
E Claudio et al.
NATURE IMMUNOLOGY (2002)
Distinctive features of nurselike cells that differentiate in the context of chronic lymphocytic leukemia
N Tsukada et al.
BLOOD (2002)
Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1)- and TNFR2-mediated apoptosis in HIV infection: relation to expression of Bcl-2 and active caspase-8 and caspase-3
LMD Pinto et al.
BLOOD (2002)
Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway
U Senftleben et al.
SCIENCE (2001)
Modulation of NF-κB activity and apoptosis in chronic lymphocytic leukemia B cells
RR Furman et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
